These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 18400559)
41. 2008 Congress of the ESFH in Düsseldorf, Germany. Moog R Transfus Apher Sci; 2009 Aug; 41(1):23-6. PubMed ID: 19556166 [No Abstract] [Full Text] [Related]
42. Adsorbent: a determinant for the future development of therapeutic apheresis. Akizawa T Ther Apher; 1998 Feb; 2(1):1-2. PubMed ID: 10227781 [No Abstract] [Full Text] [Related]
45. Apheresis medicine in the era of advanced telehealth technologies: An American Society for Apheresis position paper part II: Principles of apheresis medical practice in a 21st century electronic medical practice environment. Linz W; Andrzejewski C; Hofmann JC J Clin Apher; 2022 Feb; 37(1):122-126. PubMed ID: 34837406 [No Abstract] [Full Text] [Related]
46. Febrile transfusion reaction: what to do next? Tien SL Singapore Med J; 1993 Apr; 34(2):105-6. PubMed ID: 8266143 [No Abstract] [Full Text] [Related]
48. [Present status of the use of fresh whole blood]. Fujii H Rinsho Byori; 1991 Mar; Suppl 88():402-9. PubMed ID: 1856991 [No Abstract] [Full Text] [Related]
49. The last update of WAA apheresis registry from the user's view. Bláha M; Blazek M Transfus Apher Sci; 2007 Apr; 36(2):211-2. PubMed ID: 17369097 [No Abstract] [Full Text] [Related]
50. Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion. Vamvakas EC; Blajchman MA Transfus Med Rev; 2000 Jan; 14(1):23-33. PubMed ID: 10669938 [No Abstract] [Full Text] [Related]
51. Italy and apheresis: a fresh look at the end of 1991. Valbonesi M Transfus Sci; 1992 Jul; 13(3):349-52. PubMed ID: 10148130 [No Abstract] [Full Text] [Related]
52. This last edition of Transfusion and Apheresis Science of 2010, is substantial, with 23 full-length articles. Rock G Transfus Apher Sci; 2010 Dec; 43(3):249-250. PubMed ID: 21075687 [No Abstract] [Full Text] [Related]
53. Present status of apheresis technologies, part 3: adsorbent. Sueoka A Ther Apher; 1997 Aug; 1(3):271-83. PubMed ID: 10225751 [TBL] [Abstract][Full Text] [Related]
54. Direct oral anticoagulants in lipoprotein apheresis: handle with care. Sbrana F; Dal Pino B; Papa A; Bigazzi F; Panchetti L; Sampietro T Intern Emerg Med; 2019 Oct; 14(7):1171-1173. PubMed ID: 31165345 [No Abstract] [Full Text] [Related]
55. State of the art of therapeutic apheresis in Europe. Bosch T Ther Apher; 1999 Aug; 3(3):197-8. PubMed ID: 10427614 [No Abstract] [Full Text] [Related]
56. Update on therapeutic apheresis. Wehrli G Curr Hematol Rep; 2005 Nov; 4(6):477-82. PubMed ID: 16232386 [TBL] [Abstract][Full Text] [Related]